Home › Glycogen Storage Disease Type II › Missouri › St. Louis
Glycogen Storage Disease Type II clinical trials in St. Louis, MO
5 studies for Glycogen Storage Disease Type II are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
RecruitingPhase 1
- Washington University School of Medicine, St Louis
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
RecruitingPhase 2
- Washington University in St. Louis, St Louis
Pompe Disease Registry Protocol
RecruitingObservational study
- Washington University- Site Number : 840100, St Louis
Pompe Pregnancy Sub-Registry
RecruitingObservational study
- Washington University- Site Number : 150612, St Louis
A Global Prospective Observational Registry of Patients With Pompe Disease
RecruitingObservational study
- Washington University School of Medicine, St Louis
Glycogen Storage Disease Type II trials in other cities
- Durham, NC8 studies
- Irvine, CA5 studies
- Arlington, VA5 studies
- Philadelphia, PA4 studies
- New York City, NY4 studies
- Pittsburgh, PA4 studies
- Atlanta, GA4 studies
- Phoenix, AZ3 studies
- Cincinnati, OH3 studies
- Indianapolis, IN3 studies
- Jacksonville, FL3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer71 studies
- Breast Cancer65 studies
- Metastatic Cancer53 studies
- Colorectal Cancer49 studies
- Prostate Cancer47 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer36 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.